Ligand Pharma Sells $688K: CFO Stock Sale Spotlight
When a company's CFO divests shares amid a strong stock run, investors want to know what it means. This deep dive exp...
Understand the scenarios where Incremental Budgeting makes sense, including stability, simplicity, and historical data reliance, to choose wisely.
18,465 articlesWhen a company's CFO divests shares amid a strong stock run, investors want to know what it means. This deep dive exp...
ZachXBT has renewed scrutiny of Tokenlon, a smaller decentralized exchange, alleging illicit funds flow. Tokenlon reb...
TeraWulf stunned investors with a powerful April rally, rising about 50% as crypto momentum and cost discipline colli...
Investors are watching Criteo's early 2026 results to gauge the ad-tech pioneer's progress in privacy-friendly target...
A bizarre online listing claims a desk art piece tied to Epstein. This article explores the business case, ethics, an...
Microsoft’s 2018 GitHub acquisition is fueling a rapid AI flywheel, elevating Copilot Enterprise and Azure growth. A ...
In a choppy market, dividend stocks double right by combining reliable income with growth potential. This guide highl...
When an asset manager sells million shares of a popular bond ETF, it can signal shifts in liquidity and portfolio str...
Elliptic closes a $120 million Series D at a $670 million post-money valuation, with Deutsche Bank and Nasdaq Venture...
A thorough look at Novanta's Q1 2026 results and what they signal for novanta (novt) 2026 earnings. We break down rev...
Stran’s Q1 2026 earnings reveal a mix of steady demand and evolving margins. This article breaks down the numbers, of...
Investors weighed the promise of Milestone Pharmaceuticals against the realities of a high-stakes biotech market. Thi...